Skin barrier films are liquid formulations that protect the skin from mechanical or chemical injury and are used in post ostomy/stoma surgery. Skin barrier films are also used in the prevention of moisture-associated skin damage (MASD) which is excessive moisture caused by incontinence, perspiration, or wound drainage.
Products that form a transparent protective coating on the skin and can be safely applied to intact or broken skin without stinging may be made from a variety of substances such as acrylates, polymers both organic and inorganic, and silicone. Following the application, the barrier's liquid component evaporates, leaving a transparent, breathable protective coating.
Skin barrier films come in a variety of packaging and dispensing options such as foam applicators, sprays, wipes, and for the stoma, they come in tapes and strips.
Global Skin Barrier Products Market - Impact of the Coronavirus (COVID-19) Pandemic
The coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared the COVID-19 a pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 399 million cases and 5.75 million deaths due to coronavirus disease (COVID-19) were reported up till February 9, 2022, across the globe.
Impact of COVID-19 on Demand and Supply of Skin Barrier Products
The COVID-19 pandemic and consequent lockdown in various countries across the globe have impacted the financial status of businesses across all sectors including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry mainly due to strict lockdown in several regions. The COVID-19 pandemic has affected the economy of various regions across the globe in three main ways; 1) by directly affecting the production and demand; 2) by creating disruptions in distribution channels; 3) through its financial impact on companies and financial markets. Many countries such as Thailand, Indonesia, and Singapore are facing problems with regard to the transportation and distribution of healthcare products.
The COVID-19 caused significant disruption to the delivery of patient care across the globe, including ostomy management or stoma care. For instance, according to an article published in the British Journal of Nursing in September 2020, the number of face-to-face appointments and home visits of patients with a stoma and an ileo-anal pouch at Oxford University Hospitals NHS Foundation Trust decreased significantly between April and June 2020, causing difficulties for patients in ostomy management.
The global skin barrier products market is estimated to be valued at US$ 1,019.1 Mn in 2022 and expected to exhibit a CAGR of 4.4 % over the forecast period (2022-2030).
Figure 1: Global Skin Barrier Products Market Share (%) Analysis, By Product Type, 2022
The increasing cases of incontinence is the major factor that is expected to drive the global skin barrier products market growth over the forecast period.
The emerging prevalence of urinary or fecal incontinence is expected to drive the growth of the global skin barrier products market. For instance, according to the Journal of Urology, in clinical setting, urinary incontinence is frequently underreported and underdiagnosed. The prevalence of urinary incontinence in the U.S. was 53% from 2005 to 2016; 16% of women had mixed urinary incontinence, 26% had stress only, and 10% had urgency only. While urgency and mixed urinary incontinence were most common in women aged over 60 years, stress urinary incontinence was most common in women aged 40–59 years.
|Base Year:||2019||Market Size in 2022:||US$ 1,019.1 Mn|
|Historical Data for:||2016 to 2019||Forecast Period:||2022 to 2030|
|Forecast Period 2022 to 2030 CAGR:||4.4 %||2030 Value Projection:||US$ 1,434.6 Mn|
3M, ConvaTec Inc., Coloplast Corp., Salts Healthcare, MEDLINE, Medicareplus International, Essity Medical Solutions, Cardinal Health, Smith & Nephew Plc., Safe n Simple, B Braun Medical Inc., Hollister Inc., and DermaRite Industries, LLC.
Research and Development Activities
The increasing number of research and development activities by key market players is expected to aid in the growth of the global skin barrier products market over the forecast period. For instance, in September 2018, a controlled, randomized, prospective, open-label study was conducted in 21 healthy human volunteers to determine the durability of Cavilon Advanced Skin Protectant developed by 3M, an American multinational corporation, when applied to intact skin and compare it to three other products used for similar clinical indications. The 3M skin protectant was found to be more durable than the other products tested. It stayed on the skin for up to 7 days for all participants, whereas the other products had only 50% left on the skin at that point.
Global Skin Barrier Products Market – Regional Analysis
On the basis of region, the global skin barrier products market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to hold a dominant position in the global skin barrier products market over the forecast period, owing to new product launches of skin barrier wipes by key market players. For instance, in March 2017, ConvaTec Group Plc., a leading global medical technology company, announced the launch of Sensi-Care Skin Protectant Incontinence Wipes in the U. S., offering customers an advanced solution to help protect patients whose skin is at the risk of breakdown due to incontinence.
Moreover, due to increasing acquisitions by key market players, Europe is expected to witness significant growth in the global skin barrier products market over the forecast period. For instance, in January 2017, ConvaTec Group Plc, a leading global medical products and technologies company, announced the acquisition of EuroTec Beheer B.V., a Dutch-based manufacturer of ostomy appliances, for US$ 28 Million. Skin barrier products are used as ostomy pouch accessories. Furthermore, the addition of EuroTec to the ConvaTec family significantly strengthened their ostomy care business in France and the Benelux union.
Figure 2: Global Skin Barrier Products Market Value (US$ Mn), by Region, 2022
Global Skin Barrier Products Market – Competitive Landscape
Major players operating in the global skin barrier products market include 3M, ConvaTec Inc., Coloplast Corp., Salts Healthcare, MEDLINE, Medicareplus International, Essity Medical Solutions, Cardinal Health, Smith & Nephew Plc., Safe n Simple, B Braun Medical Inc., Hollister Inc., and DermaRite Industries, LLC.
In ostomy management, a skin barrier adheres to the peristomal (stoma) skin, protecting it from stoma output and attaching the pouch to the body. The skin barrier is separate from the pouch in a two-piece system, while in a one-piece system, they are combined.
As it protects one's skin from stoma output and keeps the pouch in place, skin barrier is the most important component of the pouching system. There are numerous skin barrier options available to provide the best seal around the stoma, prevent leakage, and protect one's skin.
Market players are focused on launching awareness campaigns related to ostomy care, which is expected to contribute to the growth of the global skin barrier products market over the forecast period. For instance, in October 2021, ConvaTec, a global medical products and technologies company, announced that to commemorate World Ostomy Day on Saturday, the company launched a month-long campaign to celebrate the ostomy community, including a Global Patient Summit. During the month of October, ConvaTec encouraged ostomates to use the hashtag #myhealthybonds to share their stories of healthy body image and medical, professional, and personal relationships on Instagram.
Market players are also focusing on adopting strategies such as acquisitions, which is expected to strengthen their position in the global skin barrier products market. For instance, in August 2020, Medline, a healthcare company, announced the acquisition of ConvaTec's SensiCare and Aloe Vesta skincare product lines. ConvaTec is a global medical products company based in the U.K. The US$ 29 million acquisition expanded Medline's portfolio of advanced skincare products to include the well-known brand of patient cleansing, moisturizing, and skin protectants.
Market players are further engaged in the expansion of their global presence by adopting strategies such as contract agreements, which is expected to drive the growth of the global skin barrier products market. For instance, in March 2021, Hollister Inc., a global medical device company and the market leader in ostomy care in the U.S., had been awarded an ostomy product contract by Vizient, Inc., a member-driven health care performance improvement company. The new agreement gives Vizient members access to the entire portfolio of Hollister Inc.’s ostomy products, including its ceramide-infused products, CeraPlus skin barriers and Adapt CeraRing barrier rings, at contracted pricing.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.